164 related articles for article (PubMed ID: 26592832)
1. Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.
Zhou X; Shi X; Ren K; Fan GT; Wu SJ; Zhao JN
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4087-97. PubMed ID: 26592832
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
Dickens DS; Cripe TP
J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
[TBL] [Abstract][Full Text] [Related]
3. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib.
Liu J; Wu J; Zhou L; Pan C; Zhou Y; Du W; Chen JM; Zhu X; Shen J; Chen S; Liu RY; Huang W
Oncotarget; 2015 Aug; 6(25):21341-52. PubMed ID: 26050198
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells.
Li S; Gu Z; Xiao Z; Zhou T; Li J; Sun K
Int J Clin Exp Pathol; 2015; 8(2):1737-42. PubMed ID: 25973062
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
6. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
[TBL] [Abstract][Full Text] [Related]
7. Icaritin suppresses the proliferation of human osteosarcoma cells in vitro by increasing apoptosis and decreasing MMP expression.
Wang XF; Wang J
Acta Pharmacol Sin; 2014 Apr; 35(4):531-9. PubMed ID: 24608674
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
Li WW; Long GX; Liu DB; Mei Q; Wang JF; Hu GY; Jiang JZ; Sun W; Gan L; Hu GQ
Pharmazie; 2014 Feb; 69(2):132-7. PubMed ID: 24640603
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
[TBL] [Abstract][Full Text] [Related]
10. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
11. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
Qorri B; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
[TBL] [Abstract][Full Text] [Related]
12. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
[TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
Kwak YE; Jeon NK; Kim J; Lee EJ
Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
15. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251.
Zhou R; Zhang LZ; Wang RZ
Chin J Cancer; 2010 Mar; 29(3):294-9. PubMed ID: 20193113
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA
Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334
[TBL] [Abstract][Full Text] [Related]
17. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
19. Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways.
Su Y; Wan D; Song W
Anticancer Drugs; 2016 Aug; 27(7):660-8. PubMed ID: 27243922
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
